At a glance
The March 8, 2021, Clinical Laboratory COVID-19 Response (CLCR) call included updates on SARS-CoV-2 variants and from the FDA and ÐÇ¿ÕÓéÀÖ¹ÙÍø Infectious Diseases Pathology Branch.

Agenda
Welcome: Jasmine Chaitram, ÐÇ¿ÕÓéÀÖ¹ÙÍø Division of Laboratory Systems (DLS)
SARS-CoV-2 Variants Update: Vivien Dugan, ÐÇ¿ÕÓéÀÖ¹ÙÍø Laboratory and Testing Task Force for the COVID-19 Response
Updates from the ÐÇ¿ÕÓéÀÖ¹ÙÍø Infectious Diseases Pathology Branch: Julu Bhatnagar, ÐÇ¿ÕÓéÀÖ¹ÙÍø Division of High-Consequence Pathogens and Pathology (DCHPP)
FDA Update: Tim Stenzel, U.S. Food and Drug Administration (FDA)